Cognex (NASDAQ:CGNX – Free Report) had its target price decreased by Truist Financial from $74.00 to $57.00 in a report released on Friday morning,Benzinga reports. Truist Financial currently has a hold rating on the scientific and technical instruments company’s stock.
Several other equities research analysts also recently issued reports on CGNX. Zacks Research downgraded Cognex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Needham & Company LLC lowered their target price on Cognex from $80.00 to $70.00 and set a “buy” rating on the stock in a research note on Friday. Cantor Fitzgerald upped their target price on Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Weiss Ratings raised shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Finally, Robert W. Baird decreased their price target on shares of Cognex from $78.00 to $70.00 and set a “neutral” rating for the company in a report on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $72.93.
Check Out Our Latest Stock Analysis on CGNX
Cognex Trading Up 0.6%
NASDAQ:CGNX traded up $0.29 during trading hours on Friday, hitting $47.78. 3,785,834 shares of the stock traded hands, compared to its average volume of 1,779,685. The firm has a 50 day moving average price of $59.06 and a 200 day moving average price of $58.04. Cognex has a fifty-two week low of $34.60 and a fifty-two week high of $72.88. The firm has a market cap of $8.04 billion, a price-to-earnings ratio of 33.41 and a beta of 1.49.
Cognex (NASDAQ:CGNX – Get Free Report) last released its earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.01. Cognex had a return on equity of 13.50% and a net margin of 16.05%. The company had revenue of $313.39 million during the quarter, compared to analyst estimates of $313.62 million. During the same quarter in the prior year, the company earned $0.33 earnings per share. The company’s revenue for the quarter was up 13.0% on a year-over-year basis. Research analysts predict that Cognex will post 1.68 EPS for the current year.
Cognex Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Investors of record on Thursday, November 19th will be issued a dividend of $0.09 per share. This is a positive change from Cognex’s previous quarterly dividend of $0.0850. This represents a $0.36 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Thursday, November 19th. Cognex’s dividend payout ratio is 23.78%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Cognex during the 2nd quarter worth about $26,000. Rakuten Securities Inc. acquired a new stake in shares of Cognex during the 2nd quarter valued at about $32,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Cognex during the 2nd quarter valued at about $32,000. Mather Group LLC. grew its stake in shares of Cognex by 81.3% in the 3rd quarter. Mather Group LLC. now owns 446 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 200 shares in the last quarter. Finally, Elevation Wealth Partners LLC grew its stake in shares of Cognex by 635.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company’s stock valued at $35,000 after buying an additional 413 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Key Stories Impacting Cognex
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: Cognex reported record Q3 results, with earnings of $0.53 per share beating estimates and revenue growing year over year. Management raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited margin expansion and stronger logistics demand. Q3 earnings call outlook and margin expansion
- Positive Sentiment: The planned RealSense acquisition could add growth opportunities, while management is targeting further margin expansion. Cognex reports record third-quarter results and RealSense acquisition
- Positive Sentiment: The company raised its quarterly dividend by 5.9% to $0.09 per share, a modest signal of confidence in cash generation.
- Negative Sentiment: Several firms cut their price targets: Stephens lowered its target to $70, KeyCorp to $65, Needham to $70, and Truist to $57. The cuts may temper enthusiasm despite the improved outlook; ratings remain mostly overweight or buy, while Truist is at hold. Stephens price-target change
Cognex Company Profile
Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.
The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.
Featured Articles
- Five stocks we like better than Cognex
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
